Gilead Science (GILD) Holder American National Insurance Company Lowered Its Holding by $6.37 Million; Intel (INTC) Stake Lifted by Rafferty Asset Management Llc

April 26, 2018 - By mmahotstuff

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

American National Insurance Company decreased its stake in Gilead Science Inc (GILD) by 46.51% based on its latest 2017Q4 regulatory filing with the SEC. American National Insurance Company sold 89,710 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 103,165 shares of the health care company at the end of 2017Q4, valued at $7.39 million, down from 192,875 at the end of the previous reported quarter. American National Insurance Company who had been investing in Gilead Science Inc for a number of months, seems to be less bullish one the $96.09B market cap company. The stock increased 0.61% or $0.45 during the last trading session, reaching $73.7. About 3.48 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 26, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Rafferty Asset Management Llc increased its stake in Intel Corp (INTC) by 56% based on its latest 2017Q4 regulatory filing with the SEC. Rafferty Asset Management Llc bought 315,996 shares as the company’s stock rose 9.61% while stock markets declined. The institutional investor held 880,322 shares of the semiconductors company at the end of 2017Q4, valued at $40.64M, up from 564,326 at the end of the previous reported quarter. Rafferty Asset Management Llc who had been investing in Intel Corp for a number of months, seems to be bullish on the $247.39 billion market cap company. The stock increased 2.92% or $1.5 during the last trading session, reaching $52.88. About 19.33 million shares traded. Intel Corporation (NASDAQ:INTC) has risen 44.65% since April 26, 2017 and is uptrending. It has outperformed by 33.10% the S&P500.

Since October 27, 2017, it had 0 insider purchases, and 15 selling transactions for $32.38 million activity. Smith Stacy J sold $20.89 million worth of stock. 8,967 shares were sold by Shenoy Navin, worth $436,410 on Friday, February 23. $25,360 worth of Intel Corporation (NASDAQ:INTC) was sold by Bryant Diane M on Friday, October 27. Another trade for 89,087 shares valued at $3.99 million was made by BRYANT ANDY D on Monday, October 30. $66,959 worth of Intel Corporation (NASDAQ:INTC) was sold by RENDUCHINTALA VENKATA S M. Shares for $31,943 were sold by McBride Kevin Thomas.

Investors sentiment decreased to 1.02 in Q4 2017. Its down 0.01, from 1.03 in 2017Q3. It turned negative, as 60 investors sold INTC shares while 703 reduced holdings. 177 funds opened positions while 601 raised stakes. 3.06 billion shares or 0.43% more from 3.05 billion shares in 2017Q3 were reported. Marathon Asset Mngmt Llp owns 2.75 million shares. Huntington Steele Ltd Company reported 0.15% in Intel Corporation (NASDAQ:INTC). L S Advisors invested in 0.68% or 96,034 shares. Piedmont Investment Advsr Lc owns 1.33M shares for 1.24% of their portfolio. Pillar Pacific Management Ltd Liability Corporation has invested 1.31% in Intel Corporation (NASDAQ:INTC). Reliance Of Delaware, a Delaware-based fund reported 98,566 shares. Connecticut-based Cubist Systematic Strategies Llc has invested 0.17% in Intel Corporation (NASDAQ:INTC). Clark Estates New York invested in 0.18% or 23,162 shares. Mitsubishi Ufj Tru And Bk invested 0.79% in Intel Corporation (NASDAQ:INTC). Wright Invsts Service Inc stated it has 1.97% of its portfolio in Intel Corporation (NASDAQ:INTC). 109,303 were reported by Benjamin F Edwards Co. First Interstate National Bank holds 0.26% in Intel Corporation (NASDAQ:INTC) or 26,832 shares. Granite Investment Prtnrs Lc has invested 0.21% of its portfolio in Intel Corporation (NASDAQ:INTC). Ifc Inc Fl owns 0.16% invested in Intel Corporation (NASDAQ:INTC) for 51,906 shares. Cleararc Cap has invested 0.75% in Intel Corporation (NASDAQ:INTC).

Among 55 analysts covering Intel Corporation (NASDAQ:INTC), 36 have Buy rating, 4 Sell and 15 Hold. Therefore 65% are positive. Intel Corporation had 249 analyst reports since August 7, 2015 according to SRatingsIntel. Mizuho maintained the shares of INTC in report on Monday, January 8 with “Buy” rating. Goldman Sachs maintained it with “Neutral” rating and $33 target in Wednesday, April 20 report. Citigroup maintained it with “Neutral” rating and $32 target in Monday, August 24 report. Mizuho maintained the shares of INTC in report on Tuesday, December 26 with “Buy” rating. Stifel Nicolaus maintained it with “Buy” rating and $53.0 target in Thursday, January 25 report. Robert W. Baird maintained the shares of INTC in report on Monday, February 26 with “Buy” rating. The stock of Intel Corporation (NASDAQ:INTC) earned “Underperform” rating by Nomura on Friday, August 21. The stock has “Sell” rating by Jefferies on Thursday, August 31. Citigroup maintained Intel Corporation (NASDAQ:INTC) on Thursday, July 21 with “Neutral” rating. The rating was maintained by RBC Capital Markets with “Sector Perform” on Monday, January 18.

Rafferty Asset Management Llc, which manages about $7.35 billion and $5.79 billion US Long portfolio, decreased its stake in Ulta Beauty Inc (NASDAQ:ULTA) by 2,144 shares to 8,136 shares, valued at $1.82 million in 2017Q4, according to the filing. It also reduced its holding in Cintas Corp (NASDAQ:CTAS) by 2,333 shares in the quarter, leaving it with 9,321 shares, and cut its stake in Aerovironment Inc (NASDAQ:AVAV).

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on May, 1 after the close. They expect $1.59 EPS, down 27.73% or $0.61 from last year’s $2.2 per share. GILD’s profit will be $2.07B for 11.59 P/E if the $1.59 EPS becomes a reality. After $1.60 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -0.63% negative EPS growth.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It turned negative, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Stralem And reported 0.15% in Gilead Sciences, Inc. (NASDAQ:GILD). Temasek (Private) invested 4.9% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Rock Point Limited Liability Co stated it has 3.91% in Gilead Sciences, Inc. (NASDAQ:GILD). Shelter Ins Retirement Plan has 42,800 shares for 1.35% of their portfolio. Sii Invests Wi accumulated 0.13% or 17,406 shares. Douglass Winthrop Advsrs Ltd Liability reported 0.07% stake. Violich Cap Mgmt invested 1.54% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Edge Wealth Management invested 2.27% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). 16,826 are owned by Miles Capital Inc. Gofen And Glossberg Ltd Liability Il accumulated 220,799 shares or 0.57% of the stock. Clearbridge Invs Ltd reported 13,512 shares. First Citizens Bankshares Tru owns 5,049 shares. Sunbelt Secs holds 0.5% or 7,236 shares in its portfolio. Legg Mason Asset Management (Japan) Co Limited reported 0.24% stake. Hermes Inv Mgmt holds 22,016 shares.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>